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ABSTRACT
Background: It is generally recommended to exercise caution in applying trauma-focused
treatment to individuals with posttraumatic stress disorder (PTSD) and comorbid borderline
personality disorder (BPD).
Objective: To investigate the effects of a brief, intensive, direct trauma-focused treatment
programme for individuals with PTSD on BPD symptom severity.
Methods: Individuals (n = 72) with severe PTSD (87.5% had one or more comorbidities;
52.8% fulfilled the criteria for the dissociative subtype of PTSD) due to multiple traumas (e.g.
90.3% sexual abuse) participated in an intensive eight-day trauma-focused treatment pro-
gramme consisting of eye movement desensitization and reprocessing (EMDR) and pro-
longed exposure (PE) therapy, physical activity, and psychoeducation. Treatment did not
include any form of stabilization (e.g. emotion regulation training) prior to trauma-focused
therapy. Assessments took place at pre- and post-treatment (Borderline Symptom List, BSL-
23; PTSD symptom severity, Clinician Administered PTSD Scale for DSM-5, CAPS-5), and
across the eight treatment days (PTSD Checklist, PCL-5).
Results: Treatment resulted in significant decreases of BPD symptoms (Cohen’s d = 0.70). Of
the 35 patients with a positive screen for BPD at pre-treatment, 32.7% lost their positive
screen at post-treatment. No adverse events nor dropouts occurred during the study time
frame, and none of the patients experienced symptom deterioration in response to
treatment.
Conclusion: The results suggest that an intensive trauma-focused treatment is a feasible
and safe treatment for PTSD patients with clinically elevated symptoms of BPD, and that
BPD symptoms decrease along with the PTSD symptoms.
El impacto del tratamiento centrado en el trauma, intensivo y breve
para el TEPT, sobre los síntomas del trastorno límite de la
personalidad
Antecedentes: generalmente se recomienda tener precaución al aplicar un tratamiento
centrado en el trauma a las personas con trastorno de estrés postraumático (TEPT)
y trastorno de personalidad límite comórbido (TPL).
Objetivo: Investigar los efectos de un programa de tratamiento breve, intensivo y directo
centrado en el trauma para personas con TEPT sobre la gravedad de los síntomas de TPL.
Métodos: los participantes (n = 72) con TEPT grave (87.5% tenían una o más comorbili-
dades; 52.8% cumplieron los criterios para el subtipo disociativo de TEPT) debido a múltiples
traumas (por ejemplo, 90.3% abuso sexual) participaron en un programa intensivo de ocho
días de tratamiento centrado en el trauma, consistente en EMDR, terapia de exposición
prolongada (PE), actividad física y psicoeducación. El tratamiento no incluyó ninguna forma
de estabilización (por ejemplo, entrenamiento de regulación emocional) antes de la terapia
centrada en el trauma. Las evaluaciones se realizaron antes y después del tratamiento (Lista
de síntomas límite, BSL-23; severidad de los síntomas de TEPT, Escala de TEPT administrada
por clínicos para DSM-5, CAPS-5) y durante los ocho días de tratamiento (Lista de
verificación de TEPT, PCL-5).
Resultados: el tratamiento resultó en una disminución significativa de los síntomas de TPL
(d de Cohen = 0.70). De los 35 pacientes con un tamizaje positivo de TPL en el pretrata-
miento, el 32,7% perdió su tamizaje positivo en el postratamiento. No ocurrieron eventos
adversos ni abandonos durante el período de tiempo del estudio, y ninguno de los
pacientes experimentó deterioro de los síntomas en respuesta al tratamiento.
Conclusión: Los resultados sugieren que un tratamiento intensivo centrado en el trauma es
un tratamiento factible y seguro para pacientes con TEPT con síntomas clínicamente
elevados de TPL, y que los síntomas de TLP disminuyen junto con los síntomas de TEPT.
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investigated the effects of
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personality disorder (BPD)
outside the context of
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• No detrimental effects of
intensive trauma-focused
treatment on BPD symptoms
occurred.
• A combination of Exposure
therapy and EMDR therapy is a
valuable option to consider
when PTSD patients are
diagnosed with additional
BPD.
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针对PTSD简短密集型聚焦创伤治疗对边缘型人格障碍症状的影响
背景:通常建议对创伤后应激障碍 (PTSD) 并发边缘型人格障碍 (BPD) 的患者进行聚焦创伤
治疗时要谨慎。
目标:考查针对PTSD简短, 密集, 直接聚焦创伤的治疗流程对BPD症状严重程度的影响。
方法:由于多重创伤 (例如90.3％的性虐待) 导致的严重PTSD (87.5％患有一种或多种并发
症； 52.8%符合PTSD分离亚型的标准) 的72名个体, 参加了一次八天的密集型聚焦创伤治
疗流程, 包括EMDR和延长暴露 (PE) 治疗, 体育锻炼和心理教育。在聚焦创伤治疗前, 疗程
不包括任何形式的稳定治疗 (例如情绪调节训练) 。在治疗前后使用《边缘型症状列表》
(BSL-23) 和《临床用DSM-Ⅳ PTSD诊断量表》 (CAPS-5的PTSD量表) 进行评估, 在整个治疗
的八天中使用《PTSD清单》 (PCL-5) 进行评估。
结果:治疗使BPD症状显著减少 (Cohen’s d= 0.70) 。在治疗前BPD筛查阳性的35例患者中,
32.7％的患者在治疗后不再是阳性。在研究时间范围内无不良事件及流失现象出现, 并且
没有患者因治疗而出现症状恶化。
结论:结果表明, 针对BPD临床症状升高的PTSD患者, 密集型聚焦创伤治疗是一种可行且安
全的疗法, 并且BPD症状随PTSD症状减轻而减轻。
The presence of posttraumatic stress disorder (PTSD)
has been found to increase the risk of developing
a range of other mental health conditions
(Perkonigg, Kessler, Storz, & Wittchen, 2000) and
comorbidity is highly prevalent in samples of patients
suffering from PTSD (Pietrzak, Goldstein, Southwick,
& Grant, 2012). For example, it has been estimated
that when diagnosed with PTSD, the risk of fulfilling
the diagnostic criteria of at least one comorbid per-
sonality disorder, such as borderline personality dis-
order (BPD), is up to 35% (Friborg, Martinussen,
Kaiser, Øvergård, & Rosenvinge, 2013).
There is a great resemblance in the aetiology and
symptomology of PTSD and BPD (Frías & Palma,
2015; Kulkarni, 2017). For instance, traumatic victi-
mization is seen as a key factor in the development of
both mental health conditions (Kulkarni, 2017).
Regarding the symptoms of (Complex) PTSD,
a study using latent class analysis on a dataset of
women with histories of childhood abuse detected
four BPD symptoms that are distinctive and that
distinguish BPD from Complex PTSD, i.e. a strong
tendency to avoid abandonment, unstable sense of
self, unstable and intense interpersonal relationships,
and impulsiveness (Cloitre, Garvert, Weiss, Carlson,
& Bryant, 2014). Conversely, core features of BPD
such as affective instability, cognitive disturbance,
interpersonal dysfunction, dissociation, and paranoid
experiences have been found in individuals suffering
from both complex PTSD and BPD (Cloitre et al.,
2014).
Despite the significant overlap in symptoms and
aetiology between the PTSD and BPD diagnoses,
there are entirely different treatment recommenda-
tions for PTSD on the one hand, and BPD (with
comorbid PTSD) on the other. International guide-
lines on the treatment of PTSD recommend
a trauma-focused treatment approach, such as pro-
longed exposure (PE) and eye movement desensitiza-
tion and reprocessing (EMDR) therapy as first-line
treatments (ISTSS Guidelines Committee, 2018;
World Health Organization, 2013). However, in the
case of BPD with comorbid PTSD, the focus of evi-
dence-based treatment is on increasing an interna-
lized and stable sense of self and reducing destructive
behaviours such as self-harm and suicidality before
treating comorbid PTSD (Bateman, Gunderson, &
Mulder, 2015; Linehan, 1993; National Collaborating
Centre for Mental Health [NCCMH], 2009). These
psychological and co-occurring social and functional
problems that are associated with BPD are the reason
that internationally respected experts exercise caution
in applying trauma-focused treatment on individuals
with PTSD and comorbid BPD (e.g. Harned, 2013).
Trauma-focused therapy would lead to complica-
tions, including those involving reduced treatment
compliance, intentional self-injury, and emotion dys-
regulation (Harned, Korslund, & Linehan, 2014), par-
ticularly in patients suffering from severe clinical
levels of BPD symptoms.
To address potential difficulties related to providing
trauma-focused therapy in these comorbid individuals,
it is often recommended to apply trauma-focused treat-
ment only after comprehensive skills training (Harned,
2013). Most of these treatment programmes include
patients with BPD and integrate trauma-focused treat-
ment (prolonged exposure) within Dialectical
Behaviour Therapy (DBT; Bohus et al., 2013; Harned
et al., 2014). One recent example is a trauma treatment
integrated within a 12-week residential treatment pro-
gramme (DBT-PTSD; Bohus et al., 2019) which
includes 19–22 sessions training in mindfulness and
compassion skills, distress tolerance skills, and emotion
regulation skills followed by one-year outpatient treat-
ment consisting of a minimum of 45 individual therapy
sessions (involving skills training, mindfulness training,
self-esteem improvement, PTSD-specific psychoeduca-
tion, and music and art therapy; Bohus et al., 2019).
Despite the diversity of treatment interventions and the
relatively long duration, such treatment programmes
have been found effective, feasible, and safe, thereby
confirming the assumption that trauma-focused
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interventions must be preceded or accompanied by
skills training aimed at interrupting dissociation and
improving emotion regulation to tolerate the PTSD
treatment.
To test the assumption that emotion regulation diffi-
culties indeed have a negative impact on trauma-focused
treatment, Jerud, Pruitt, Zoellner, and Feeny (2016)
examined the efficacy of direct trauma-focused treatment
(prolonged exposure or Sertraline) in a sample of 200
individuals with PTSD with various levels of emotion
regulation abilities. They found that individuals’ emotion
regulation skills significantly improved following
trauma-focused treatment without any prior emotion
regulation skill training, especially for those individuals
who had poorer emotion regulation at baseline. These
results are consistent with the findings that PTSD may
intensify symptoms of BPD, resulting in emotion dysre-
gulation (e.g. Cackowski, Neubauer, & Kleindienst,
2016), or overlap with BPD symptoms (Cloitre et al.,
2014). Hence, BPD symptoms may decrease when
PTSD symptoms decline, and skill training to address
the BPD symptoms beforehand may not be necessary.
Only a few studies have evaluated the impact of trauma-
focused treatment on symptoms of BPD. For example, in
an uncontrolled open pilot study with BPD patients and
those with other personality disorders who also suffered
from PTSD, the application of trauma-focused (i.e.
EMDR) therapy appeared effective in terms of
a significant reduction of PTSD symptoms (Slotema,
van den Berg, Driessen, Wilhelmus, & Franken, 2019).
No differences in outcome were found between the
group with BPD (n = 16) and the group with other
personality disorders (n = 16). However, although the
median number of sessions of completers was only four
sessions of 60–90 minutes, the total drop out was 32%,
and because therapy was applied as an addition to treat-
ment as usual for personality disorders, the effect of
trauma-focused treatment on borderline symptoms is
unknown. If we consider the reverse relationship, namely
the impact of the severity of BPD symptoms on trauma-
focused treatment outcome, it appears that none of the
studies that investigated this relationship found outcome
to be related to the severity of BPD symptoms (Bohus
et al., 2013; Clarke, Rizvi, & Resick, 2008; Hendriks, de
Kleine, Broekman, Hendriks & Van Minnen, 2018).
These findings cast doubts on the need to exclude
patients with high levels of BPD symptoms from trauma-
focused treatment.
In the last decade, short and highly intensive trauma-
focused treatment programmes have been developed
(Ehlers et al., 2014; Meyers et al., 2017). These pro-
grammes show that it is possible to intensify trauma-
focused treatment for PTSD patients exposed to a wide
variety of multiple traumas, including childhood sexual
abuse, and suffering from high rates of comorbidity,
dissociative symptoms, and suicidal ideation, while
symptom worsening and patient dropout appears to
be rare (Hendriks et al., 2018; Van Woudenberg et al.,
2018; Wagenmans, Van Minnen, Sleijpen, & De Jongh,
2018). The purpose of the current study was to evaluate
the effects of a brief intensive trauma-focused treatment
programme (Van Woudenberg et al., 2018), that does
not contain any explicit form of training in emotion
regulation skills, for PTSD patients with clinically ele-
vated levels of borderline symptoms.Wewere primarily
interested in the extent to which this treatment affected
borderline symptom severity. Given the aforemen-
tioned overlap in aetiology and symptoms, it was
hypothesized that symptoms of BPD would signifi-
cantly decrease following treatment. Furthermore,
because of the alleged difficulties concerning trauma-
focused treatment of individuals with PTSD and
comorbid BPD, it was predicted that individuals with
clinically elevated symptoms of BPD would profit sig-
nificantly less from trauma-focused treatment, com-
pared to those with no or few symptoms of BPD. One
feature that might negatively influence the outcome of
trauma-focused treatment is dissociation (e.g. Lanius,
Brand, Vermetten, Frewen &Spiegel, 2012). Therefore,
we also examined whether individuals who met the
criteria for the dissociative subtype of PTSD would
show a significantly poorer improvement regarding
their borderline symptoms associated with treatment
than patients who did not meet these criteria. Finally,
to investigate patient safety and potential negative reac-
tions to the intervention, the proportion of patients
experiencing PTSD symptom worsening and dropout
were determined.
1. Methods
1.1. Participants
Patients were enrolled in a short intensive treatment
programme for PTSD at the Psychotrauma Expertise
Centre (PSYTREC), a mental health centre in
Bilthoven, the Netherlands, and were treated from June
to August 2017. Before entering treatment, psychologists
assessed whether patients met the inclusion criteria, i.e.
(1) being at least 18 years old, (2) having a diagnosis of
PTSD according to the DSM-5 (American Psychiatric
Association [APA], 2013), (3) being able to speak and
understand the Dutch language, and (4) no attempts of
suicide three months prior to beginning of therapy.
Ethical exemption of the study protocol was appointed
by the Medical Ethics Review Committee of VU
University Medical Centre (registered with the US
Office for Human Research Protections (OHRP) as
IRB00002991, FWA number FWA00017598).
1.2. Procedure
Patients were referred for treatment by their general
practitioner, psychologist, psychiatrist, or other mental
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health centres. During intake, the Clinician
Administered PTSD Scale (CAPS-5; Boeschoten et al.,
2018) was administered to establish a PTSD diagnosis,
and the Mini International Neuropsychiatric Interview
(MINI) was used to establish comorbid psychiatric dis-
orders. Patients completed the borderline symptom list
(BSL-23; Bohus et al., 2009) after the intake session at
home. At intake, a treatment plan for eight days was
established with at least eight traumatic memories
according to, and ordered based upon, the level of
disturbance (i.e. memories with the highest subjective
units of disturbance first). After the intake procedure,
the eight-day intensive treatment started during which
patients stayed at the clinic. After the first four treat-
ment days, patients went home for three days, after
which they returned for the second series of four days.
At the beginning of the first therapy session of each
treatment day, patients were asked to complete the
PTSD Checklist (PCL-5; Weathers et al., 2013) At post-
treatment, nine days after the last treatment day, the
CAPS-5 and BSL-23 were administered again.
1.3. Treatment programme
Each day of treatment consisted of an individual PE
session of 90 minutes in the morning and an indivi-
dual EMDR therapy session of 90 minutes in the
afternoon. Additionally, patients participated in phy-
sical activity four times a day with a total of six hours
per day provided by professional physical trainers.
Patients also attended two hours of psychoeducation
per day presented by psychologists. Both physical
activity sessions and psychoeducation were provided
in groups. No relaxation or emotion regulation skills
training was applied prior to the processing of their
memories (see De Jongh et al., 2016, for the ratio-
nale). To avoid confounding of elements of stabiliza-
tion and trauma-focused therapy, the second phase
(i.e. safe place exercise section) was removed from the
standard EMDR protocol.
Treatment sessions were employed by clinical psy-
chologists, trained in both EMDR and PE therapy.
The PE protocol largely followed the approach of Foa,
Hembree, and Rothbaum (2007). According to this
approach, patients were asked to imagine the mem-
ories of the traumatic events as vividly as possible and
had to describe their traumatic memories in the pre-
sent tense, out loud and in detail. During treatment,
in vivo exposure to feared but safe trauma-related
stimuli was used.
The EMDR therapy protocol used followed the
eight phases approach of Shapiro (2017) and de
Jongh and Ten Broeke (2013). During treatment,
patients were asked to memorize the most distressing
part of the experienced trauma while their working
memory capacities are challenged by visually tracking
the finger movements of the therapist or other stimuli
to maximize the work load of the working memory,
such as a light bar, clicking sounds, and/or hand-held
buzzers. The flashforward protocol (Logie & De
Jongh, 2014) was used for treatment of irrational
fears and avoidance behaviour in case of anticipatory
fear (e.g. of getting overwhelmed by their memories
or their emotions).
Between the trauma-focused sessions patients par-
ticipated in a physical activity programme of six hours
per day. The physical activity programme included
low and high intensity activities such as mountain
biking and hiking. The two hours of psychoeducation
per day consisted of PTSD-related topics, such as
symptoms of PTSD, and avoidance and safety
behaviours.
1.4. Measurements
The primary outcome measure was the severity of
BPD symptoms, assessed by the Borderline
Symptom List (BSL-23; Bohus et al., 2009; Leenarts,
Boonman, Diehle, & Rinne, 2009). The BSL-23 is
a self-report measure and includes 23 items on
a Likert scale from 0 (not at all) to 4 (very much)
and has a good test-retest reliability over a one-week
period, and a high internal consistency (Bohus et al.,
2009). The internal consistency in the current study
was very good (α = .94). A mean item score between
1.5 and 2 indicates the presence of a clinically ele-
vated level of BPD symptoms (Glenn, Weinberg, &
Klonsky, 2009). Using a stringent cut-off score, we
categorized patients into ‘positive screen for BPD’
when they scored a mean item score of ≥ 2, and
into ‘negative screen for BPD’ when they scored
a mean item score of < 2.
PTSD diagnosis and symptom severity were
assessed by using the Dutch version of the Clinician
Administered PTSD Scale for DSM-5 (CAPS-5;
Boeschoten et al., 2018; Weathers et al., 2017). The
CAPS-5 measures the severity of PTSD. Psychometric
evaluation demonstrates a high internal consistency
and a good validity (Boeschoten et al., 2018;
Weathers et al., 2017). The CAPS includes two sepa-
rate items representing the symptoms of the dissocia-
tive subtype: depersonalization and derealization.
Using the conservative score rule of frequency ≥ 2
and severity ≥ 2 on at least one of these items,
patients were classified as meeting or not meeting
the criteria of the dissociative subtype.
To be able to monitor the change in PTSD symp-
toms during treatment, the PTSD Checklist (PCL-5;
Weathers et al., 2013) was administered at each of the
eight treatment days. The PCL-5 is a self-report mea-
sure of PTSD and includes 20 items that correspond
to the symptoms in the DSM-5 (APA, 2013) and are
rated from 0 (not at all) to 4 (extremely).
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Psychometric evaluation demonstrates a high internal
consistency and good validity (Bovin et al., 2016).
The Dutch version of Mini-International
Neuropsychiatric Interview (MINI; Overbeek,
Schruers, & Griez, 1999; Sheehan et al., 1998) is
a structured diagnostic interview used to asses psy-
chiatric disorders and suicide risk. The MINI appears
to be reliable and well-validated (Overbeek et al.,
1999; Sheehan et al., 1998).
1.5. Statistical analyses
SPSS version 25 was used to perform all statistical
analyses. Participants were excluded from analysis if
missing data exceeded 10% of the total number of
items of the CAPS-5 or the BSL-23. Person mean
imputation was performed when missing values did
not exceed this percentage. The average item score
for each participant was computed and imputed for
the missing items for that participant (Hawthorne &
Elliott, 2005). Independent t-test and chi-square ana-
lyses were conducted to compare pre-treatment dif-
ferences (gender, age, type of trauma, and CAPS-5
score at pre-treatment) between the group of partici-
pants excluded for analyses due to missing data and
the analysed group.
A mixed-design analysis of variance was used to
determine the impact of treatment on BPD symptoms,
and of BPD symptoms on PTSD symptoms as mea-
sured with either CAPS-5 or PCL-5. The between sub-
jects factor included BPD symptoms (positive or
negative screen for BPD) and the within subjects factor
included time (BSL-23, CAPS-5, or PCL-5 scores).
Preliminary analyses indicated no violations of assump-
tions of additivity and linearity, normality, homogene-
ity of variance, and independence. Also, the additional
assumption of homogeneity of intercorrelations was
not violated. A Greenhouse-Geisser correction was
applied when the violation of sphericity was violated.
To determine whether individuals experienced clinical
reliable worsening of PTSD symptoms a reliable change
(RC) index was calculated to determine whether
patients’ CAPS scores changed beyond a level that
could be attributed to measurement error alone
(Evans, Margison & Barkham, 1989). Within effect
sizes were calculated using Cohen’s d formula, which
divides the difference of the means by the weighted
pooled standard deviations of these groups (Cohen,
2013). A mixed analysis of variance was conducted to
determine possible differences between patients who
had the dissociative subtype of PTSD at baseline and
those who did not. One patient had missing data on the
CAPS items representing the symptoms of the dissocia-
tive subtype. Therefore, this analysis included 71
patients. Effect sizes were interpreted by the guidelines
of Cohen (1988), considering 0.2 or less as a small effect,
0.5 a medium effect, and 0.8 or greater a large effect.
The level of significance for all statistical analyses in this
study was set at a = .05.
2. Results
2.1. Patient flow and sample characteristics
The patient flow is presented in Figure 1. A total of
99 participants entered the study and were eligible for
research. All participants provided informed consent
for participation, nine were excluded because they
lacked a baseline BSL measurement, and 18 lacked
a post-treatment BSL measurement.
Accordingly, in total 72 participants (81.9%
women), with a mean age of 38.9 years (SD = 13.2),
were included in this study. Post-treatment CAPS-5
data were missing for one patient. Baseline character-
istics of study participants are displayed in Table 1.
Figure 1. Participant flow chart used in analysis.
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Participants had been exposed to a wide variety of
multiple traumatic events, including sexual abuse
(90.3%). Individuals with a positive screen for BPD
at baseline had experienced physical abuse signifi-
cantly more often than those with a negative screen
(p = .023). The treatment sample represented a severe
PTSD patient population in that they showed high
comorbidity rates (87.5% had one or more comorbid-
ities), more than half (53.5%) fulfilled the criteria for
the dissociative subtype of PTSD, and the majority
(47.2%) reported an elevated suicide risk. Thirty-five
patients (48.6% of the sample) fulfilled the criterion
of a ‘positive screen’ for BPD at baseline, and they
showed significantly higher BSL-23, CAPS-5, and
PCL-5 scores at baseline than patients with
a negative screen for BPD (BSL-23: t(70) = −12.42,
p < .001; CAPS-5: t(70) = −2.41, p = .019; PCL-5: t
(70) = −5.15, p < .001). There were no significant
differences between the two groups with regard to
gender, type of trauma, and comorbidity.
2.2. Change in borderline symptom severity
A mixed-design ANOVA showed a significant main
effect of time with BSL-23 scores decreasing during
treatment (F(1, 70) = 37.55, p < .001, ƞ2 = 0.35; see
Table 2 for mean BSL-23 scores and effect sizes).
Furthermore, a significant main effect for BPD screen
was found (F(1, 70) = 66.54, p < .001, ƞ2 = 0.49)
There was a significant interaction effect between
time and BPD screen, indicating that the effect of
time significantly differed between those with
a negative and a positive BPD screen (F(1,
70) = 6.62, p = .012, ƞ2 = 0.09, see also Figure 2).
Those with a positive screen for BPD showed
a significantly greater decrease in BSL-23 scores com-
pared to patients with a negative screen for BPD. Of
the 35 patients who met the criteria of a positive
screen for BPD, 32.7% no longer met these criteria
after treatment.
2.3. Change in PTSD symptom severity (CAPS-5)
Patients in the total group showed a decrease in
PTSD symptoms from baseline to post-treatment as
measured with the CAPS-5 (Cohen’s d = 1.24). The
mixed-design ANOVA showed a significant main
effect of time (F(1, 69) = 115.90, p < .001,
ƞ2 = 0.63). Also, a main significant effect for BPD
screen was found (F(1, 69) = 14.47, p < .001,
ƞ2 = 0.17). There was a significant interaction effect
between time and BPD screen, indicating that
Table 1. Baseline characteristics of patients with a negative and a positive screen for borderline personality disorder.
Total group
N = 72
Negative screen
n = 37
Positive screen
n = 35 Test values
Variable N (%) n (%) n (%) χ2 value p-value**
Gender
Female 59 (81.9) 31 (83.8) 28 (80) 0.174 .677
Trauma exposure
Sexual abuse 65 (90.3) 31 (83.8) 34 (97.1) 3.66 .056
Physical abuse 58 (80.6) 26 (70.3) 32 (91.4) 5.14 .023
Work-related trauma 7 (9.7) 4 (10.8) 3 (8.6) 0.10 .749
Accidents, disasters, or war violence 17 (23.6) 9 (24.3) 8 (22.9) 0.02 .884
Comorbidity
Depressive episode 40 (55.6) 17 (45.9) 23 (65.7) 2.847 .092
Dysthymia 8 (11.1) 3 (8.1) 5 (14.3) 0.695 .404
Anxiety disorder 48 (66.7) 23 (62.2) 25 (71.4) 0.695 .404
Alcohol dependency 11 (15.3) 7 (18.9) 4 (11.4) 0.780 .377
Dissociative subtype
No 33 (46.5) 18 (50) 15 (42.9) 0.364 .546
Yes 38 (53.5) 18 (50) 20 (57.1)
Suicidal ideation
No 14 (19.4) 10 (27) 4 (11.4)
Low 24 (33.3) 13 (35.1) 11 (31.4) 4.186 .242
Medium 10 (13.9) 5 (13.5) 5 (14.3)
High 24 (33.3) 9 (24.3) 15 (42.9)
M (SD) M (SD) M (SD) t-value p-value
Age 38.85 (13.21) 39.14 (13.29) 38.54 (13.31) 0.189 .851
*Differences between continuous variables tested with t-tests and between categorical variables with Chi square.
**Bonferroni corrected alpha level is 0.05/13 = 0.004.
Table 2. BSL-23, CAPS-5, and PCL-5 scores at pre- and post-
treatment.
Variable
Pre-treatment
M (SD)
Post-treatment
M (SD) Cohen’s d
BSL-23
Total group 2.01 (0.89) 1.42 (1.06)* 0.70
Negative screen 1.35 (0.48) 0.97 (0.88)* 0.49
Positive screen 2.82 (0.52) 1.89 (1.04)* 0.92
CAPS-5
Total group 45.61 (7.74) 24.77 (16.46)* 1.24
Negative screen 43.54 (7.69) 19.84 (15.57)* 1.60
Positive screen 47.80 (7.28) 32.24 (15.08)* 0.96
PCL-5
Total group 53.33 (12.09) 28.13 (21.23)* 1.34
Negative screen 47.22 (10.46) 20.84 (18.87)* 1.45
Positive screen 59.80 (12.27) 35.83 (21.11)* 1.22
BSL-23 = Borderline Symptom List-23, CAPS-5 = Clinician Administered
PTSD Scale, PCL-5 = PTSD Checklist for DSM-V.
* = p < .01.
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patients with a negative screen for BPD showed
a significantly larger decline in PTSD symptoms
from pre-treatment to post-treatment than those
with a positive BPD screen (F(1, 69) = 4.77,
p = .032, ƞ2 = 0.65).
2.4. Course of PTSD symptoms during the
eight days of treatment
Figure 3 shows the mean PCL-5 scores at each of the
eight treatment days for each group. A mixed-design
ANOVA showed a significant main effect of time
with PCL-5 scores decreasing during treatment (F
(4.397, 294.566) = 40.923, p < .001, ƞ2 = 0.38).
Again, a significant main effect for BPD screen was
found (F(1, 70) = 20.86, p < .001, ƞ2 = 0.23). There
was no significant interaction effect between time and
BPD screen, indicating that the effect of time did not
significantly differ for those with a negative and posi-
tive BPD screen (F(4.397, 294.566) = 0.911, p = .564,
ƞ2 = 0.013).
2.5. Borderline symptom change compared
between individuals with and without
dissociative subtype
A mixed-design ANOVA showed a significant main
effect of time [F(1, 69) = 36.45, p < .001,n2p = .346]
with both groups showing a change in BSL-23 scores
over time. The main effect comparing both dissocia-
tion groups was not significant [F(1, 69) = 0.72,
p = .398,n2p = .010] indicating that the BSL-23 scores
were not significantly different between the dissocia-
tion group and the group without dissociation at pre-
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Figure 2. Mean BSL-23 item scores pre- and post-treatment.
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Figure 3. Mean PTSD symptom scores as measured with PCL-5 at each treatment day for individuals with positive and negative
screens for BPD.
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treatment (M = 2.17, SD = 0.86 vs M = 1.96,
SD = 0.94) and at post-treatment (M = 1.47,
SD = 0.99 vs M = 1.33, SD = 1.15). Also, the interac-
tion between time and group was not significant [F(1,
69) = 0.085, p = .772,n2p = .001] which suggests that
the change over time did not differ between the
dissociation groups.
2.6. Patient safety and adverse events
Adverse events and attrition were monitored for the
duration of the study by therapists and staff. No
adverse events occurred during the study time
frame and there was no dropout in this study
group. None of the patients and, hence, no patients
with a positive screen for BPD, experienced clinically
reliable worsening of PTSD symptoms.
3. Discussion
To our knowledge, this is the first study that evalu-
ated the effects of an intensive trauma-focused ther-
apy programme for patients with PTSD on comorbid
BPD symptoms. The main finding was that the treat-
ment programme was well tolerated with medium to
large effect sizes regarding both BPD and PTSD
symptoms. After this brief treatment, one-third of
the PTSD patients who met a positive screen for
BPD before treatment no longer fulfilled this criter-
ion after treatment. Importantly, no dropout nor any
adverse events occurred.
Hence, the data were supportive of the hypothesis
that symptoms of BPD would decrease significantly
associated with intensive trauma-focused treatment
aimed at resolving the memories that were driving
the PTSD. This finding is in line with those support-
ing positive treatment effects of trauma-focused treat-
ment in individuals with PTSD and comorbid BPD
(e.g. Harned, Ruork, Liu, & Tkachuck, 2015; Steuwe
et al., 2016). However, the difference is that the cur-
rent treatment programme, which combined two
trauma-focused guideline therapies for PTSD, was
much shorter and did not contain any explicit form
of training in emotion regulation skills, nor any form
of intervention aimed at reducing destructive beha-
viours, such as self-harm and suicidality prior to
treatment. The finding that improvement of border-
line symptoms did not differ between individuals
who fulfilled the diagnostic criteria of the dissociative
sub-type of PTSD as indexed by the CAPS-5 and
those who did not meet the criteria of this condition
is consistent with earlier findings of our treatment
programme in another sample of patients (Zoet,
Wagenmans, Van Minnen, Sleijpen, & De Jongh,
2018). More generally, the results are in line with
findings that, overall, comorbid psychopathological
symptoms improve as a result of successful trauma-
focused therapy (Van Minnen, Zoellner, Harned, &
Mills, 2015) and with studies, showing that direct
trauma-focused treatment is a feasible option for
individuals with symptoms of BPD (Hendriks et al.,
2018; Meyers et al., 2017).
One explanation for the finding that the key symp-
toms of BPD decreased might be related to the fact that
all participants in this study had been exposed to child-
hood adversities or multiple other traumas and suffered
from severe symptoms of (complex) PTSD. Given the
resemblance in terms of affective instability and inter-
personal dysfunction being present in individuals suf-
fering from both (complex) PTSD and BPD (Cloitre
et al., 2014; Kulkarni, 2017), a reduction in PTSD
symptoms might also have resulted in a reduction of
BPD symptoms. Furthermore, it is likely that the inten-
sive treatment format had a positive effect on some of
the clinical complexities of BPD such as treatment non-
compliance and co-occurring psychological, social, and
functional problems (Harned, 2013). In addition,
patients might be more focused on treating their
PTSD, instead of problems related to relationships or
suicidal ideation. Moreover, the short duration of the
treatment with a fixed and predictable conclusion of
therapy could have contributed to the results and may
also explain the lack of dropout in the present study.
Partial support was also found for the hypothesis
that PTSD patients with a positive screen for BPD
would profit significantly less from trauma-focused
treatment in terms of decline of PTSD symptoms,
compared to those with a negative screen for BPD.
Although regarding our self-report measure PCL-5
no differences were found, the clinician’s rated
PTSD Scale showed that PTSD patients with
a positive screen for BPD did not perform as well.
On the one hand, the BSL-23 items, that are based on
criteria of the DSM-IV, the revised version of the
Diagnostic Interview for BPD, and opinions of both
clinical experts and BPD patients, partly contain
items that operationalize factors that are distinctive
for BPD (Cloitre et al., 2014). This particularly holds
true for items that relate to self-organization symp-
toms that define both the Complex PTSD and BPD
diagnoses. However, the BSL-23 contains virtually no
items that measure symptoms characteristic of PTSD.
Therefore, it was to be expected that those who
scored high on the BSL-23 would benefit less from
a treatment that was mainly aimed at reducing PTSD
symptomatology. Likewise, this finding is consistent
with opinions of experts and current treatment guide-
lines recommending a focus on symptoms character-
istic of BPD such as the reduction of self-destructive
behaviours and with treatment guidelines in which
trauma-focused treatment for patients with BPD is
discouraged (Bateman et al., 2015; Linehan, 1993;
NCCMH, 2009). On the other hand, also for the
patients high on BPD symptoms, the effect sizes
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were still large. That patients high on BPD symptoms
responded to a lesser degree than those low on BPD
might mean that these patients, who also started
higher on PTSD symptoms, would need more treat-
ment sessions for their PTSD symptoms to decrease.
It would be enlightening to test this hypothesis in
a future study. Clearly, the processing of traumatic
experiences does not automatically lead to the devel-
opment of new skills sets and patients with more
severe BPD symptoms may need additional treatment
for their symptoms. However, the present results
contradict the DBT philosophy of a staged hierarchy
approach where PTSD symptoms are treated only
after extensive skill training. One might argue that
treatment of PTSD leads to subsequent changes in
emotions and cognitions that enable behaviour
change to occur more efficiently after PTSD treat-
ment. With this in mind, it would be interesting to
study whether, and if so, for whom, which form of
skill training would be effective after instead of before
trauma-focused treatment.
Some study limitations are worth noting. First and
foremost, the current study design lacked the methodo-
logical rigour that is associated with a randomized con-
trolled trial such as blinding to condition and
a comparison group with minimal bias and confound-
ing factors. Despite these inherent limitations, the cur-
rent study retains a high degree of rigour by the
application of very straight forward treatment package
with fixed time schedules and 16 sessions of two well
validated evidence based trauma-focused therapies for
PTSD. Therapists were instructed to perform the thera-
pies according to written protocols and, to assure that
the therapies were delivered according to these proto-
cols, supervisors were present during the daily multi-
disciplinary meetings. Other important limitations
include the lack of follow-up measurements and
a control group which makes it difficult to demonstrate
durable non-transient ‘halo’ effects, and to determine
whether these effects were due to the intensive trauma-
focused treatment programme or to other factors.
Although it could be argued that it is unlikely that the
change in BPD symptom can be explained as ‘placebo
effects’ or attributed to spontaneous improvement,
symptom fluctuation, or regression to the mean, repli-
cation using a RCT design is certainly required.
Another reason why we need to be cautious in inter-
preting the present findings is that patients high on
borderline symptoms were not officially diagnosed
with BPD. However, the BSL-23 has been found to be
strongly associated with the presence of DSM BPD
symptoms as assessed by valid semi-structured inter-
views (i.e. the Structured Interview for Diagnostic and
Statistical Manual of Mental Disorders, fourth Edition,
Personality Disorders [SIDP-IV]), thereby supporting
the BSL-23 as a valid and clinically useful measure of
BPD symptomatology (Glenn et al., 2009). In addition,
we used a stringent cut-off score for the BSL-23. Yet, the
use of a structured interview for diagnosing BPD would
certainly have contributed to the reliability of the
results. A final limitation of current research has to do
with the exclusion criterion; that is, not to admit people
to the treatment programme who have attempted sui-
cide in the last threemonths, and this may have resulted
in people with severe borderline patients not participat-
ing in the study. However, we used very few exclusion
criteria, and our patients had a high level of comorbid-
ity, including high levels of suicidality, and our mean
item-scores on the BSL-23 were comparable (M = 2.01,
SD = 0.89) to those of Bohus et al. (2007; M = 2.05;
SD = 0.90) in a sample of 379 psychiatric in- and out-
patients who met the DSM criteria for BPD.
In conclusion, to our knowledge this is the first
study to investigate the effect of intensive PTSD
treatment including EMDR and PE with regard to
BPD symptoms in a relatively large sample of
patients. Although symptoms of BPD reduced as
a result of direct trauma-focused treatment, patients
with a positive screen for BPD profit less from inten-
sive treatment for PTSD compared to patients with
a negative screen (note however that there were no
differences in self-reported PTSD symptoms). Yet,
the present findings do not support the notion of
detrimental effects of trauma-focused treatment on
BPD symptoms and suggest that an intensive trauma-
focused treatment programme can lead to PTSD
symptom reduction among patients with a high
level of BPD symptoms without significant exacerba-
tion of these symptoms. Accordingly, the findings of
this study have many implications for clinical practice
in that a brief intensive trauma-focused treatment
might be a valuable option to consider when PTSD
patients are diagnosed with additional BPD. If the
present results could be replicated using well-
designed studies and implemented in other settings,
this could greatly reduce the cost of mental health
care for this target group.
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